Our clinical experiences relation to reducing volume of local anesthetic in intravenous regional anesthesia
İbrahim Öztürk, Hüseyin Balkarlı, İsmail Çakıcı
Abstract
İbrahim Öztürk, Hüseyin Balkarlı, İsmail Çakıcı
Abstract
Objectives: We aimed to assess safety of lidocaine at small volume (≤15 mL) and high concentration (%2) in intravenous regional anaesthesia of upper extremity. Methods: Data of patients underwent upper extremity surgery by intravenous regional anesthesia with ≤15 mL 2% lidocaine between November 2010 and November 2011, were retrospectively analyzed. Results: A total of 54 patients between 35-62 years old have been received lidocaine in median 250.74±12.71 mg dosage and 12.54±0.63 mL volume. Onset time and recovery time of sensory and motor blocks have been reached at acceptable levels. Hemodynamic data have been maintained stable. Quality of anesthesia has been assessed as 74.1% excellent, and as 25.9% good. In patients in whom temporary tinnitus (7.4%), dizziness (5.6%) and tachycardia (3.7%) have been observed, no serious adverse effects had been observed. Conclusion: Use of lidocaine, at high concentration and small volume, has provided safe and easy administration in recommended dosage interval.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectives: We aimed to assess safety of lidocaine at small volume (≤15 mL) and high concentration (%2) in intravenous regional anaesthesia of upper extremity. Methods: Data of patients underwent upper extremity surgery by intravenous regional anesthesia with ≤15 mL 2% lidocaine between November 2010 and November 2011, were retrospectively analyzed. Results: A total of 54 patients between 35-62 years old have been received lidocaine in median 250.74±12.71 mg dosage and 12.54±0.63 mL volume. Onset time and recovery time of sensory and motor blocks have been reached at acceptable levels. Hemodynamic data have been maintained stable. Quality of anesthesia has been assessed as 74.1% excellent, and as 25.9% good. In patients in whom temporary tinnitus (7.4%), dizziness (5.6%) and tachycardia (3.7%) have been observed, no serious adverse effects had been observed. Conclusion: Use of lidocaine, at high concentration and small volume, has provided safe and easy administration in recommended dosage interval.
Key concepts: Medicine, Lidocaine, Anesthesia, Adverse effect, Intravenous regional anesthesia, Local anesthetic, Anesthetic, Tinnitus